Local reactions to the second dose of the BNT162 COVID-19 vaccine
Dermatol Ther
.
2021 Jul;34(4):e15000.
doi: 10.1111/dth.15000.
Epub 2021 Jun 1.
Authors
Antonella Tammaro
1
,
Ganiyat Adenike Ralitsa Adebanjo
1
,
Francesca Romana Parisella
2
,
Gabriella De Marco
1
,
Jordi Rello
3
4
5
Affiliations
1
Department of NESMOS Dermatology, Sapienza University of Rome, Rome, Italy.
2
Department of Medicine, University of Queensland, Brisbane, Australia.
3
Centro de Investigación Biomedica en Red de Enfermedades Respirorias (CIBERES), Instituto Salud Carlos III, Madrid, Spain.
4
Clinical Research/Epidemiology in Pneumonia and Sepsis (CRIPS), Vall d'Hebron Institut of Research (VHIR), Barcelona, Spain.
5
Clinical Research, CHU Nîmes, Université Montpellier-Nimes, Nîmes, France.
PMID:
34031953
PMCID:
PMC8209913
DOI:
10.1111/dth.15000
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Vaccination
Substances
COVID-19 Vaccines